The turmoil at the FDA continues with the news that Tracy Beth Høeg has been fired as acting head of the FDA's Center for ...

Germany's Merck KGaA is looking at making further acquisitions to boost its business, according to chief executive Belén Garijo. The CEO – who is due to step down next April after five years in the ...

Boehringer Ingelheim's alliance with digital health company Brainomix on an AI-enabled tool for diagnosing interstitial lung ...

Khalil Asmar, VP of cardiometabolic health at Lilly UK & Ireland (l), and former England spin bowler Ashley Giles (r). Like ...

Big Tech platforms continue to roll out AI health assistants at scale, with Amazon’s new agent the latest to be integrated ...

MSD is scrapping a £1 billion ($1.35 billion) expansion of its UK operations – including a facility already under construction in London – saying the country does not value innovative medicines. The ...

Regenxbio is pitching at FDA approval next year for its Duchenne muscular dystrophy (DMD) gene therapy RGX-202, after ...

The Supreme Court of the US has ruled that the abortion pill mifepristone can continue to be prescribed remotely and delivered by mail-order, overruling an appeals court decision earlier this month.

AI company Anthropic and the Gates Foundation have said they will provide $200 million in funding for a programme to support the development of AI for "health, life sciences, education, and economic ...

Bladder cancer has been billed by AstraZeneca as a key growth area for its immunotherapy Imfinzi, an ambition that has now ...

Novo Nordisk has identified a group of early responders to its high-dose Wegovy formulation that shed almost 28% of their ...